These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 15244199

  • 1. Serum paraoxonase levels in gastric cancer.
    Akçay MN, Yilmaz I, Polat MF, Akçay G.
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxiii-cclxxv. PubMed ID: 15244199
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
    Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I.
    Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
    [Abstract] [Full Text] [Related]

  • 4. Significance of alterations in plasma lipid profile levels in breast cancer.
    Franky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, Patel HR, Prabhudas Shankerbhai Patel.
    Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA.
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S.
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease.
    Verit FF, Erel O, Celik N.
    Hum Reprod; 2008 Jan; 23(1):100-4. PubMed ID: 18000171
    [Abstract] [Full Text] [Related]

  • 10. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES.
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [Abstract] [Full Text] [Related]

  • 11. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
    Guo E, Chen L, Xie Q, Chen J, Tang Z, Wu Y.
    Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
    [Abstract] [Full Text] [Related]

  • 12. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.
    J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487
    [Abstract] [Full Text] [Related]

  • 13. [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].
    González AI, Brites F, Elbert A, Gómez-Rosso L, Berg G, Wikinski R, Schreier L.
    Medicina (B Aires); 2010 Apr 15; 70(6):508-12. PubMed ID: 21163737
    [Abstract] [Full Text] [Related]

  • 14. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
    Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S.
    BMC Cancer; 2007 Mar 15; 7():48. PubMed ID: 17362500
    [Abstract] [Full Text] [Related]

  • 15. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ, Braschi S, Willis G, Astley SB.
    Clin Sci (Lond); 2005 Aug 15; 109(2):189-97. PubMed ID: 15853770
    [Abstract] [Full Text] [Related]

  • 16. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
    Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW.
    Curr Med Res Opin; 2007 Sep 15; 23(9):2235-40. PubMed ID: 17692153
    [Abstract] [Full Text] [Related]

  • 17. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb 15; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 18. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 01; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 20. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
    Paragh G, Törocsik D, Seres I, Harangi M, Illyés L, Balogh Z, Kovács P.
    Curr Med Res Opin; 2004 Aug 01; 20(8):1321-7. PubMed ID: 15324535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.